Dashboard
Explore Stocks
Pricing
About
Sign Up
Summary
Intrinsic Value
Fundamental Analysis
Wall Street Estimates
Dividend Analysis
Competition
Ownership
News
Profile Summary
Financials
Income Statement
Balance Sheet
Cash Flow
DCF Valuation
Earnings Call
Dividends
Wall Street Estimates
Read Financial Reports
Stock Analysis Checklist
Amneal Pharmaceuticals, Inc. AMRX
Healthcare - Drug Manufacturers - Specialty & Generic - NYSE - US
Watchlist
$ 7.21
-2.3 %
$ 3.36 B
Market Cap
-18.97
P/E
Price Target
Average
47.02%
Revenue Forecast
Estimate
11.33%
EBIT
Estimate
--11.80%
Net Income
Estimate
41.42%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Amneal Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for
AMRX
of
$10.6
, with forecasts ranging from a low of
$9
to a high of
$12
.
AMRX Lowest Price Target
Wall Street Target
9 USD
24.83%
AMRX Average Price Target
Wall Street Target
10.6 USD
47.02%
AMRX Highest Price Target
Wall Street Target
12 USD
66.44%
Price
Max Price Target
Min Price Target
Average Price Target
12
12
11
11
10
10
9
9
8
8
7
7
6
6
5
5
May '24
May '24
Jul '24
Jul '24
Aug '24
Aug '24
Oct '24
Oct '24
Nov '24
Nov '24
2025
2025
Feb '25
Feb '25
Apr '25
Apr '25
Jun '25
Jun '25
Jul '25
Jul '25
Aug '25
Aug '25
Oct '25
Oct '25
Nov '25
Nov '25
2026
2026
Feb '26
Feb '26
Apr '26
Apr '26
REVENUE FORECAST
Revenue Forecast Chart
AMRX
$3.5b
$3.5b
$3.0b
$3.0b
$2.5b
$2.5b
$2.0b
$2.0b
$1.5b
$1.5b
$1.0b
$1.0b
$500.0m
$500.0m
$0.0
$0.0
2018
2018
2019
2019
2020
2020
2022
2022
2023
2023
2024
2024
2025
2025
2026
2026
2027
2027
EBIT FORECAST
EBIT Forecast Chart
AMRX
$300.0m
$300.0m
$200.0m
$200.0m
$100.0m
$100.0m
$0.0
$0.0
($100.0m)
($100.0m)
($200.0m)
($200.0m)
($300.0m)
($300.0m)
($400.0m)
($400.0m)
2018
2018
2019
2019
2020
2020
2022
2022
2023
2023
2024
2024
2025
2025
2026
2026
2027
2027
NET INCOME FORECAST
Net Income Chart
AMRX
$300.0m
$300.0m
$200.0m
$200.0m
$100.0m
$100.0m
$0.0
$0.0
($100.0m)
($100.0m)
($200.0m)
($200.0m)
($300.0m)
($300.0m)
($400.0m)
($400.0m)
($500.0m)
($500.0m)
($600.0m)
($600.0m)
($700.0m)
($700.0m)
2018
2018
2019
2019
2020
2020
2022
2022
2023
2023
2024
2024
2025
2025
2026
2026
2027
2027
Upgrade a Plan
If you need more info, please check
Pricing Guidelines
.
Free
forever, no credit card required
$
0
/ Mon
Up to 3 Valuations Access per week
Only 1 Watchlist
Select
Unlimited Plan
No restrictions, no limits.All stocks, all tools.
$
15.00
/ month
All stocks, all tools.
No restrictions, no limits.
Select Plan
Premium Plan
Enough to check your investmentsfrom time to time.
$
9.00
/ month
15 stocks per week
Enough to check investments
Select Plan
Add Note
Capture your thoughts
Note
Sell
Buy
Hold
Pass